UK advises limiting AstraZeneca in under-30s amid clot worry – Twin Cities

2021-04-07 15:39:43 –


London (AP) — British officials will not vaccinate adults under the age of 30 with the AstraZeneca COVID-19 vaccine on Wednesday to strengthen evidence that shots may be associated with rare blood clots. I recommended that.

Regulators in the United Kingdom and the European Union issued this recommendation because they emphasized that the benefits of vaccination continue to outweigh the risks of most people. Rare blood clot. British authorities have recommended providing AstraZeneca alternatives to people under the age of 30. However, the EMA does not recommend such age restrictions and it is up to the Member States to decide whether to limit their use.

Some countries have already imposed restrictions on those who can receive the vaccine, and vaccines that are cheaper and easier to store than many others are important for global vaccination campaigns, and the United Nations Restrictions are carefully monitored as they are the pillars of the supporting program, known as the COVAX, which aims to vaccinate some of the poorest countries in the world.

“This is a modification of the course and there is no doubt about it,” Jonathan Vantam, Deputy Chief Medical Officer in the United Kingdom, said at a news conference.

Van-Tam has an impact on the UK vaccination schedule (one of the fastest in the world), assuming the National Health Service receives the expected delivery of other vaccines, including those manufactured by Pfizer-BioNTech and Moderna. One) said it should be “zero or negligible”.

EU and UK regulators held a simultaneous press conference on Wednesday to publish findings on reports of blood clots that raised concerns about the deployment of the AstraZeneca vaccine.

EU agencies have described blood clots as a “very rare” side effect. Dr. Sabine Straus, chair of the Safety Commission, said the best data came from Germany, with one report of blood clots for every 100,000 doses, but far fewer in the UK. It was. Another expert, Dr. Peter Arlet, states that healthy women face oral contraceptives.

Authorities were unable to identify specific risk factors based on current information, but said most of the reported cases were women under the age of 60 within two weeks of vaccination. Experts have reviewed dozens of cases, primarily from Europe and the United Kingdom. There, about 25 million people were vaccinated with the AstraZeneca vaccine.

“The risk of death from COVID is much greater than the risk of death from these side effects,” said Emer Cooke, EMA Secretary-General.

Arlett said there was no information suggesting an increased risk from other major COVID-19 vaccines.

In a statement, AstraZeneca said both UK and EU regulators demanded that vaccine labels be updated to warn of these “very rare potential side effects.”

“Both of these reviews reaffirmed that the vaccine provided a high level of protection against all severity of COVID-19 and that these benefits far outweigh the risks,” he said. I did.

The EMA study focused on an abnormal type of blood clot that occurred with a decrease in platelets. One rare clot type appears in multiple blood vessels and the other in the veins that drain blood from the brain.

Wei Shen Lim, chair of the UK’s Joint Committee on Immunization and Immunization, said: “We recommend that certain age groups prioritize one vaccine over another … not because of serious safety concerns, but with great care. “

In March, the use of AstraZeneca was stopped, mainly in more than 12 European countries, due to blood clot problems. Most have resumed — some have age restrictions — after the EMA has stated that countries should continue to use the vaccine.

But Britain, which relies heavily on AstraZeneca, continued to use it.

The suspension was considered particularly damaging as it occurred after repeated failures of AstraZeneca’s method of reporting data on vaccine efficacy and how well its injections worked in the elderly. It was. As a result, advice on who can be vaccinated is frequently changed in some countries, raising concerns that AstraZeneca’s credibility will be permanently compromised, vaccine hesitation will increase, and pandemics may be prolonged. I am.

Dr. Peter English, a former chairman of the British Medical Association’s Public Health Commission, said the round trip over the AstraZeneca vaccine could have serious consequences.

“If you’re going to end the pandemic, you can’t help but use this vaccine,” he said.

In some countries, authorities have already pointed out that they are hesitant to shoot AstraZeneca.

Florentina Nastase, physician and coordinator at the Vaccination Center in Bucharest, Romania, said: “Sometimes people didn’t come, and sometimes they came to the center and saw that they were using only AstraZeneca and refused to get vaccinated.”

Meanwhile, the Veneto Governor of northern Italy said early Wednesday that the decision to change guidance on AstraZeneca caused a great deal of confusion in vaccination and prevented it when Europe was already struggling to step up vaccination. He said it could cause further confusion about vaccination.

“Put yourself on behalf of the citizens. It’s hard to understand anything,” Luka Zia told reporters.

The latest outage of AstraZeneca occurred in the Castile and Leon region of Spain. There, on Wednesday, Health Director Veronica Cassard temporarily withheld a vaccine that she supported as still effective and necessary due to the “principle of prudence.”

French health officials, like some Asian officials, said they were waiting for the EMA’s conclusions.

South Korea announced on Wednesday that it would temporarily suspend the use of AstraZeneca’s vaccine for people under the age of 60. In that age group, the country currently only vaccinates health care workers and people in long-term care facilities.

Immediately after the announcement of the EMA, Belgian Minister of Health Frank Vandenbroucke said the country would ignore the advice of the authorities. He has declared a four-week ban on AstraZeneca vaccines for people under the age of 56, but this month there will be little impact on vaccination campaigns as there are few vaccinations from that age group. Said.

Italian health officials also said Wednesday that AstraZeneca would be recommended for people over the age of 60.

“For the vast majority of people, the benefits of the Oxford AZ vaccine far outweigh the very small risks,” said Dr. Anthony Hahnden, Vice Chairman of the UK Immunization Commission. “And the Oxford AZ vaccine will continue to save many from suffering the catastrophic effects that can result from COVID infections.”


This story has been updated to correct the incorrect title in English in the second reference. He is a former chairman of the British Medical Association’s Public Health Medical Committee. It has also been updated to clarify that the recommendations on who should receive AstraZeneca injections are from the UK Government vaccine agency.


Associated Press writer Lauran Neergaard in Alexandria, Virginia, Mike Corder in Amsterdam, Joseph Wilson in Barcelona, ​​Spain, Colleen Barry in Milan, Kim Tong-hyung in Seoul, Angela Charlton in Paris, Raf Casert in Brussels, Bucharest, Romania. Nicolae Dumitrache contributed to this report.


Follow AP’s pandemic coverage below.




UK advises limiting AstraZeneca in under-30s amid clot worry – Twin Cities Source link UK advises limiting AstraZeneca in under-30s amid clot worry – Twin Cities

Back to top button